A.M. Domeney

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity.

Joel W. Hughes, P. Boden, B. Costall et al. · Proceedings of the National Academy of Sciences · 1990 · 504 citations · Full text

Molecular Pharmacology, Maze Test, Potent Anxiolytic Activity +12

Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome

Christian Heidbreder, Isabelle Weiss, A.M. Domeney et al. · Neuroscience · 2000 · 400 citations

Social Isolation, Behavioral Sciences, Endocrinological Characterization +11

Effects of the 5‐HT₃ receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

B. Costall, A.M. Domeney, R.J. Naylor et al. · British Journal of Pharmacology · 1987 · 355 citations · Full text

The potential anxiolytic activity of GR38032F, a 5‐HT₃‐receptor antagonist

Brian J. Jones, B. Costall, A.M. Domeney et al. · British Journal of Pharmacology · 1988 · 328 citations · Full text

The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates

Janine M. Barnes, B. Costall, J. Coughlan et al. · Pharmacology Biochemistry and Behavior · 1990 · 195 citations

Neurophysiology, Neuroanatomy, Behavioral Neuroscience +12